Business Description
Future Medicine Co Ltd
ISIN : KR7341170009
Compare
Compare
Traded in other countries / regions
341170.Korea IPO Date
2022-07-27Description
Future Medicine Co Ltd is a drug development company. It engages in the development of new drug candidates for anti-inflammatory/anti-fibrosis of non-alcoholic hepatitis (NASH) drugs, oral glaucoma treatments, and chronic kidney disease treatments, as well as targeted and Immuno cancer drugs.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.38 | |||||
Equity-to-Asset | 0.3 | |||||
Debt-to-Equity | 1.86 | |||||
Debt-to-EBITDA | -0.65 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 25.2 | |||||
3-Year EPS without NRI Growth Rate | 18.9 | |||||
3-Year FCF Growth Rate | 13.1 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 43.29 | |||||
9-Day RSI | 42.78 | |||||
14-Day RSI | 45.11 | |||||
6-1 Month Momentum % | -58.23 | |||||
12-1 Month Momentum % | -59.61 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.36 | |||||
Quick Ratio | 1.36 | |||||
Cash Ratio | 1.28 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -17.6 | |||||
Shareholder Yield % | -24.97 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -396.95 | |||||
ROA % | -100.01 | |||||
ROIC % | -140.51 | |||||
ROC (Joel Greenblatt) % | -715.72 | |||||
ROCE % | -282.06 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 15.97 | |||||
Price-to-Tangible-Book | 18.9 | |||||
EV-to-EBIT | -4.91 | |||||
EV-to-EBITDA | -5.31 | |||||
EV-to-FCF | -5.97 | |||||
Price-to-Net-Current-Asset-Value | 45.2 | |||||
Price-to-Net-Cash | 85.05 | |||||
Earnings Yield (Greenblatt) % | -20.36 | |||||
FCF Yield % | -14.95 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Future Medicine Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | |||
EPS (TTM) (â‚©) | -612 | ||
Beta | 0 | ||
Volatility % | 71.05 | ||
14-Day RSI | 45.11 | ||
14-Day ATR (â‚©) | 187.505303 | ||
20-Day SMA (â‚©) | 3049.75 | ||
12-1 Month Momentum % | -59.61 | ||
52-Week Range (â‚©) | 1940 - 8960 | ||
Shares Outstanding (Mil) | 10.53 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Future Medicine Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Future Medicine Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
Future Medicine Co Ltd Frequently Asked Questions
What is Future Medicine Co Ltd(XKRX:341170)'s stock price today?
The current price of XKRX:341170 is â‚©2890.00. The 52 week high of XKRX:341170 is â‚©8960.00 and 52 week low is â‚©1940.00.
When is next earnings date of Future Medicine Co Ltd(XKRX:341170)?
The next earnings date of Future Medicine Co Ltd(XKRX:341170) is .
Does Future Medicine Co Ltd(XKRX:341170) pay dividends? If so, how much?
Future Medicine Co Ltd(XKRX:341170) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |